UNH Quote, Financials, Valuation and Earnings

The Cigna Group has a net margin of 5.5% compared to UnitedHealth Group's net margin of 2.17%. UnitedHealth Group's return on equity of 14.34% beat The Cigna Group's return on equity of 8.07%.

UnitedHealth Group has a consensus price target of $628.30, signalling upside risk potential of 20.11%. On the other hand The Cigna Group has an analysts' consensus of $362.55 which suggests that it could grow by 9.53%. Given that UnitedHealth Group has higher upside potential than The Cigna Group, analysts believe UnitedHealth Group is more attractive than The Cigna Group.

UnitedHealth Group has a beta of 0.607, which suggesting that the stock is 39.293% less volatile than S&P 500. In comparison The Cigna Group has a beta of 0.506, suggesting its less volatile than the S&P 500 by 49.385%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.61%. The Cigna Group offers a yield of 1.73% to investors and pays a quarterly dividend of $1.51 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. The Cigna Group pays out 45.63% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $100.8B, which are larger than The Cigna Group quarterly revenues of $65.7B. UnitedHealth Group's net income of $5.5B is higher than The Cigna Group's net income of $1.4B. Notably, UnitedHealth Group's price-to-earnings ratio is 33.75x while The Cigna Group's PE ratio is 27.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.21x versus 0.38x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.

Centene has a net margin of 5.5% compared to UnitedHealth Group's net margin of 0.69%. UnitedHealth Group's return on equity of 14.34% beat Centene's return on equity of 12.3%.

UnitedHealth Group has a consensus price target of $628.30, signalling upside risk potential of 20.11%. On the other hand Centene has an analysts' consensus of $78.62 which suggests that it could grow by 30.07%. Given that Centene has higher upside potential than UnitedHealth Group, analysts believe Centene is more attractive than UnitedHealth Group.

UnitedHealth Group has a beta of 0.607, which suggesting that the stock is 39.293% less volatile than S&P 500. In comparison Centene has a beta of 0.529, suggesting its less volatile than the S&P 500 by 47.066%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.61%. Centene offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Centene pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $100.8B, which are larger than Centene quarterly revenues of $40.8B. UnitedHealth Group's net income of $5.5B is higher than Centene's net income of $283M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.75x while Centene's PE ratio is 9.69x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.21x versus 0.19x for Centene. Usually stocks with elevated PS ratios are considered overvalued.

Elevance Health has a net margin of 5.5% compared to UnitedHealth Group's net margin of 0.92%. UnitedHealth Group's return on equity of 14.34% beat Elevance Health's return on equity of 14.4%.

UnitedHealth Group has a consensus price target of $628.30, signalling upside risk potential of 20.11%. On the other hand Elevance Health has an analysts' consensus of $498.18 which suggests that it could grow by 15.14%. Given that UnitedHealth Group has higher upside potential than Elevance Health, analysts believe UnitedHealth Group is more attractive than Elevance Health.

UnitedHealth Group has a beta of 0.607, which suggesting that the stock is 39.293% less volatile than S&P 500. In comparison Elevance Health has a beta of 0.773, suggesting its less volatile than the S&P 500 by 22.685%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.61%. Elevance Health offers a yield of 1.53% to investors and pays a quarterly dividend of $1.71 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Elevance Health pays out 25.22% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $100.8B, which are larger than Elevance Health quarterly revenues of $45.4B. UnitedHealth Group's net income of $5.5B is higher than Elevance Health's net income of $418M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.75x while Elevance Health's PE ratio is 16.90x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.21x versus 0.57x for Elevance Health. Usually stocks with elevated PS ratios are considered overvalued.

Molina Healthcare has a net margin of 5.5% compared to UnitedHealth Group's net margin of 2.39%. UnitedHealth Group's return on equity of 14.34% beat Molina Healthcare's return on equity of 25.84%.

UnitedHealth Group has a consensus price target of $628.30, signalling upside risk potential of 20.11%. On the other hand Molina Healthcare has an analysts' consensus of $338.46 which suggests that it could grow by 3.28%. Given that UnitedHealth Group has higher upside potential than Molina Healthcare, analysts believe UnitedHealth Group is more attractive than Molina Healthcare.

UnitedHealth Group has a beta of 0.607, which suggesting that the stock is 39.293% less volatile than S&P 500. In comparison Molina Healthcare has a beta of 0.701, suggesting its less volatile than the S&P 500 by 29.866%.

UnitedHealth Group has a quarterly dividend of $2.10 per share corresponding to a yield of 1.61%. Molina Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. UnitedHealth Group pays 52.29% of its earnings as a dividend. Molina Healthcare pays out -- of its earnings as a dividend. UnitedHealth Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

UnitedHealth Group quarterly revenues are $100.8B, which are larger than Molina Healthcare quarterly revenues of $10.5B. UnitedHealth Group's net income of $5.5B is higher than Molina Healthcare's net income of $251M. Notably, UnitedHealth Group's price-to-earnings ratio is 33.75x while Molina Healthcare's PE ratio is 16.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for UnitedHealth Group is 1.21x versus 0.47x for Molina Healthcare. Usually stocks with elevated PS ratios are considered overvalued.